M. Martínez Villacampa

First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours

Javier Sastre, Bartomeu Massutí, G. Pulido et al. · European Journal of Cancer · 2015 · 57 citations · Full text

Medicine, Geriatric Medicine, Oncology +13

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features

Ramón Salazar, Jaume Capdevila, Berta Laquente et al. · BMC Cancer · 2015 · 51 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Metastatic burden in nude mice organs measured using prostate tumor PC-3 cells expressing the luciferase gene as a quantifiable tumor cell marker

Núria Rubio, M. Martínez Villacampa, Nadia El Hilali et al. · The Prostate · 2000 · 43 citations

Medicine, Cancer Biology, Oncology +17

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

Cristina Santos, Adriana López‐Doriga, M. Navarro et al. · Colorectal Disease · 2012 · 40 citations

Medicine, Oncology, Surgery +17

Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker.

Núria Rubio, M. Martínez Villacampa, Jerónimo Blanco · PubMed · 1998 · 23 citations

Medicine, Cancer Biology, Oncology +14